Superfund Research Program
Dissecting the Signaling Network for Ah Receptor-mediated B-cell Toxicity
Project Leader: Russell S. Thomas (The Hamner Institutes for Health Sciences)
Co-Investigators: Melvin E. Andersen (ScitoVation LLC), Norbert E. Kaminski
Grant Number: P42ES004911
Funding Period: 2006-2020
Project Summary (2006-2013)
A comprehensive evaluation of human exposure pathways at Superfund sites reveals that contaminants functioning as Ahr agonists present a significant risk to surrounding residents and immunological effects are one of the least studied toxciological end points. The primary objectives of this project are two-fold: (1) dissect the gene expression cascade involved in suppression of B-cell activation and IgM secretion following exposure to Ahr agonists; (2) combine information on the gene expression cascade with a comprehensive survey of protein interactions and focused molecular experimentation to create an integrated, systems-level model of the role of Ahr in the B-cell differentiation signaling network. These researchers hypothesize that multiple nodes in the B-cell differentiation network are regulated by the Ahr. By dissecting the interrelationships within the gene expression cascade together with a comprehensive protein interaction map, they are able to mechanistically model the dose-response behavior for Ahr B-cell immunotoxicity. This hypothesis is tested using a unique combination of genomic and computational tools that dissect the transcriptional cascades following exposure to an Ahr agonist and infer the corresponding structure of the cellular signaling network for computational modeling. Project investigators are: (1) identifying Ahr-dependent alterations in the B-cell gene expression cascade following activation with LPS and exposure to the prototype Ahr agonist TCDD; (2) characterizing the direct, cis-acting effects of Ahr activation on primary changes in gene expression in the B-cell differentiation cascade; (3) delineating the interrelationships between primary gene expression events and secondary and tertiary gene expression changes for Ahr-mediated alterations in B-cell differentiation; and (4) combining information on the Ahr-regulated B-cell gene expression cascade with a comprehensive survey of protein interactions and focused molecular experimentation to create an integrated, systems-level computational model of the Ahr and B-cell differentiation signaling network. Through these specific aims, this research team is developing a systems-level approach that provides a quantitative and mechanistic understanding of the cellular signaling network involved in the suppression of B-cell differentiation by Ahr agonists. Specifically, genomic tools provide snapshots into transcriptional responses and functional relationships between genes in the B-cell differentiation pathway, while computational modeling is used to provide a quantitative biological structure to the signaling network. The development of a systems approach is significant for the environmental health community as a whole by providing a mechanism to systematically investigate the cause-and-effect relationships contained within the lists of altered genes and the underlying logic of the signaling network involved in producing the toxicological effect at environmentally relevant doses.